lobbying_activities: 2862094

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2862094	f6a94a7d-a614-4c2e-b3a9-32b8e713bdac	Q3	PENN AVENUE PARTNERS	400918672	ALKERMES, INC.	2022	third_quarter	PHA	Regulatory and legislative issues impacting Alkermes. S.3593 - Telehealth Extension and Evaluation Act.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2022-10-10T21:26:28-04:00